'Although the molecular cause of sickle cell had been known since 1956, pharma had never shown much interest. Industry had yet to realize that rare diseases could be lucrative. And the few they invested in tended to be conditions, like hemophilia and cystic fibrosis, that primarily affected white people. CF also received far more philanthropic and government funding, greasing the wheels for therapies that have transformed the disease.'

#SickleCell #PublicHealth #DrugDevelopment

https://www.statnews.com/2022/12/19/new-drugs-for-sickle-cell-few-prescriptions/?utm_medium=social&utm_source=mastodon&utm_campaign=mastodon_organic